StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.99−0.25 (-4.77%)

Close on Nov 17, 2026Market cap $489.46MP/E –Yield –

aTYR PHARMA total assets

Total assets on the balance sheet at the end of each period.

aTYR PHARMA's total assets was $69.83M at Jun 30, 2026. For fiscal 2025 it was $93.00M, down 4.0% from the year before. Over ten years it grew -3.3% a year on average. The highest annual figure on record is $129.68M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$93.00M-4.0%
FY2024Dec 31, 2024$96.83M-19.7%
FY2023Dec 31, 2023$120.65M+26.0%
FY2022Dec 31, 2022$95.79M-17.1%
FY2021Dec 31, 2021$115.54M+198.3%
FY2020Dec 31, 2020$38.73M+7.0%
FY2019Dec 31, 2019$36.19M-31.4%
FY2018Dec 31, 2018$52.75M-41.0%
FY2017Dec 31, 2017$89.36M+11.0%
FY2016Dec 31, 2016$80.52M-37.9%
FY2015Dec 31, 2015$129.68M+528.1%
FY2014Dec 31, 2014$20.64M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$69.83M-31.2%
Q1 FY2026Mar 31, 2026$79.65M-18.1%
Q4 FY2025Dec 31, 2025$93.00M-4.0%
Q3 FY2025Sep 30, 2025$106.65M+16.4%
Q2 FY2025Jun 30, 2025$101.53M-4.2%
Q1 FY2025Mar 31, 2025$97.25M-14.1%
Q4 FY2024Dec 31, 2024$96.83M-19.7%
Q3 FY2024Sep 30, 2024$91.62M-26.7%
Q2 FY2024Jun 30, 2024$105.94M-20.2%
Q1 FY2024Mar 31, 2024$113.25M-17.2%
Q4 FY2023Dec 31, 2023$120.65M+26.0%
Q3 FY2023Sep 30, 2023$125.07M+30.2%
Q2 FY2023Jun 30, 2023$132.75M+38.3%
Q1 FY2023Mar 31, 2023$136.84M+30.6%
Q4 FY2022Dec 31, 2022$95.79M-17.1%
Q3 FY2022Sep 30, 2022$96.06M-22.5%
Q2 FY2022Jun 30, 2022$96.02M+96.0%
Q1 FY2022Mar 31, 2022$104.78M+90.1%
Q4 FY2021Dec 31, 2021$115.54M+198.3%
Q3 FY2021Sep 30, 2021$123.92M+197.6%
Q2 FY2021Jun 30, 2021$49.00M+3.0%
Q1 FY2021Mar 31, 2021$55.13M+1.3%
Q4 FY2020Dec 31, 2020$38.73M+7.0%
Q3 FY2020Sep 30, 2020$41.64M-4.8%
Q2 FY2020Jun 30, 2020$47.56M-2.5%
Q1 FY2020Mar 31, 2020$54.45M+9.1%
Q4 FY2019Dec 31, 2019$36.19M-31.4%
Q3 FY2019Sep 30, 2019$43.75M-26.8%
Q2 FY2019Jun 30, 2019$48.76M-28.6%
Q1 FY2019Mar 31, 2019$49.92M-36.4%
Q4 FY2018Dec 31, 2018$52.75M-41.0%
Q3 FY2018Sep 30, 2018$59.77M-36.7%
Q2 FY2018Jun 30, 2018$68.31M+11.1%
Q1 FY2018Mar 31, 2018$78.47M+19.4%
Q4 FY2017Dec 31, 2017$89.36M+11.0%
Q3 FY2017Sep 30, 2017$94.49M+10.0%
Q2 FY2017Jun 30, 2017$61.47M–
Q1 FY2017Mar 31, 2017$65.74M–
Q4 FY2016Dec 31, 2016$80.52M–
Q3 FY2016Sep 30, 2016$85.93M–

More aTYR PHARMA figures

See a number that looks wrong?